Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Endocrinology|November 4, 2011
Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional combined tumorCharlotte Lepoutre-Lussey, Audrey Rousseau, Abir Al Ghuzlan, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2011
Doxorubicin and ifosfamide for high-grade sarcoma during pregnancyOlivier Mir, Narjiss Berrada, Julien Domont, et al.
Investigational New Drugs|December 8, 2010
Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinibNathalie Lassau, Linda Chami, Serge Koscielny, et al.
The Oncologist|March 14, 2015
Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyomaAndrew S Brohl, Li Li, Vaagn Andikyan, et al.
The Oncologist|August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2010
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibChee Khoon Lee, David Goldstein, Emma Gibbs, et al.
The Lancet. Oncology|September 25, 2010
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trialAxel Le Cesne, Isabelle Ray-Coquard, Binh Nguyen Bui, et al.
Cancer|November 3, 2011
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomasAntoine Italiano, Angela Cioffi, Nicolas Penel, et al.
Cancer|April 17, 2013
Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO)Christine Chevreau, Axel Le Cesne, Isabelle Ray-Coquard, et al.
Pageof 3